Approval · Notice of Compliance 2693 · 1998
PRANDASE: Notice of Compliance 2693
Issued March 24, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2693
- Date
- March 24, 1998
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change to dosage regimen
- Therapeutic class
- Oral antidiabetic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRANDASE | Not yet assigned | — |